0001209191-20-009282.txt : 20200213
0001209191-20-009282.hdr.sgml : 20200213
20200213165221
ACCESSION NUMBER: 0001209191-20-009282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200213
DATE AS OF CHANGE: 20200213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waldin Jan-Paul
CENTRAL INDEX KEY: 0001733176
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37347
FILM NUMBER: 20611589
MAIL ADDRESS:
STREET 1: 77 KING STREET WEST
STREET 2: SUITE 3000
CITY: TORONTO
STATE: A6
ZIP: M5K 1G8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XBiotech Inc.
CENTRAL INDEX KEY: 0001626878
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-386-2930
MAIL ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-12
0
0001626878
XBiotech Inc.
XBIT
0001733176
Waldin Jan-Paul
77 KING STREET WEST
SUITE 3000
TORONTO
A6
M5K 1G8
ONTARIO, CANADA
1
0
0
0
Common Stock
2020-02-12
4
D
0
95612
30.00
D
204388
D
- Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. The number of shares reported is an estimate, and will be amended when a final determination is made.
/s/ Queena Han under Power of Attorney for Jan-Paul Waldin
2020-02-13